BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11960919)

  • 1. Overexpression of a dominant-negative ornithine decarboxylase in mouse skin: effect on enzyme activity and papilloma formation.
    Shantz LM; Guo Y; Sawicki JA; Pegg AE; O'Brien TG
    Carcinogenesis; 2002 Apr; 23(4):657-64. PubMed ID: 11960919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted antizyme expression in the skin of transgenic mice reduces tumor promoter induction of ornithine decarboxylase and decreases sensitivity to chemical carcinogenesis.
    Feith DJ; Shantz LM; Pegg AE
    Cancer Res; 2001 Aug; 61(16):6073-81. PubMed ID: 11507056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse skin chemical carcinogenesis is inhibited by antizyme in promotion-sensitive and promotion-resistant genetic backgrounds.
    Feith DJ; Shantz LM; Shoop PL; Keefer KA; Prakashagowda C; Pegg AE
    Mol Carcinog; 2007 Jun; 46(6):453-65. PubMed ID: 17219416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: relevance to genetically mediated differences in promotion susceptibility.
    Imamoto A; Beltrán LM; Fujiki H; Chenicek KJ; DiGiovanni J
    Carcinogenesis; 1992 Feb; 13(2):177-82. PubMed ID: 1740006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin.
    Smith MK; Trempus CS; Gilmour SK
    Carcinogenesis; 1998 Aug; 19(8):1409-15. PubMed ID: 9744537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice.
    Morikawa T; Wanibuchi H; Morimura K; Ogawa M; Fukushima S
    Jpn J Cancer Res; 2000 Jun; 91(6):579-81. PubMed ID: 10874208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of C57Bl/6 mice from a tumor promotion-resistant to a -sensitive phenotype by enhanced ornithine decarboxylase expression.
    Guo Y; Zhao J; Sawicki J; Peralta Soler A; O'Brien TG
    Mol Carcinog; 1999 Sep; 26(1):32-6. PubMed ID: 10487519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes.
    Bomser J; Singletary K; Meline B
    Chem Biol Interact; 2000 Jun; 127(1):45-59. PubMed ID: 10903418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.
    Takigawa M; Simsiman RC; Boutwell RK
    Cancer Res; 1986 Jan; 46(1):106-12. PubMed ID: 3940182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of a functionally altered ornithine decarboxylase activity in chrysarobin-promoted mouse epidermal papillomas.
    O'Brien TG; O'Donnell K; Kruszewski FH; DiGiovanni J
    Carcinogenesis; 1988 Nov; 9(11):2081-5. PubMed ID: 3141077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of phorbol ester promotion in the resistant C57BL/6J mouse with sustained hyperplasia but not ornithine decarboxylase or protein kinase C.
    Fischer SM; Jasheway DW; Klann RC; Butler AP; Patrick KE; Baldwin JK; Cameron GS
    Cancer Res; 1989 Dec; 49(23):6693-9. PubMed ID: 2819717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of application frequency on epidermal ornithine decarboxylase induction by chrysarobin in SENCAR mice.
    Kruszewski FH; Chenicek KJ; Digiovanni J
    Cancer Lett; 1986 Sep; 32(3):263-9. PubMed ID: 3768852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of epidermal protein kinase C activity, ornithine decarboxylase induction and DNA synthesis stimulated by TPA or dioctanoylglycerol in mouse strains with differing susceptibility to TPA-induced tumor promotion.
    Mills KJ; Smart RC
    Carcinogenesis; 1989 May; 10(5):833-8. PubMed ID: 2706740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of ornithine decarboxylase expression in 12-O-tetradecanoylphorbol-13-acetate-treated mouse skin and in epidermal tumors.
    Gilmour SK; Aglow E; O'Brien TG
    Carcinogenesis; 1986 Jun; 7(6):943-7. PubMed ID: 2423265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by putrescine of the induction of epidermal ornithine decarboxylase activity and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate.
    Weekes RG; Verma AK; Boutwell RK
    Cancer Res; 1980 Nov; 40(11):4013-8. PubMed ID: 7471050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
    Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
    Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced synthesis of epidermal ornithine decarboxylase messenger RNA and diacylglycerol-promoted mouse skin tumor formation by retinoic acid.
    Verma AK
    Cancer Res; 1988 Apr; 48(8):2168-73. PubMed ID: 3349487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyamines modulate carcinogen-induced mutagenesis in vivo.
    Wallon UM; O'Brien TG
    Environ Mol Mutagen; 2005; 45(1):62-9. PubMed ID: 15611981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tip60 protein isoforms and altered function in skin and tumors that overexpress ornithine decarboxylase.
    Hobbs CA; Wei G; DeFeo K; Paul B; Hayes CS; Gilmour SK
    Cancer Res; 2006 Aug; 66(16):8116-22. PubMed ID: 16912189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
    Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
    Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.